A comparison of early diagnostic utility of Alzheimer disease biomarkers in brain magnetic resonance and cerebrospinal fluid.

@article{Argils2014ACO,
  title={A comparison of early diagnostic utility of Alzheimer disease biomarkers in brain magnetic resonance and cerebrospinal fluid.},
  author={Jos{\'e} Antonio Monge Argil{\'e}s and Mar{\'i}a Amparo Blanco Cant{\'o} and C Leiva Salinas and Luc{\'i}a Flors and C Mu{\~n}oz Ru{\'i}z and Jos{\'e} S{\'a}nchez Pay{\'a} and R Gasparini Berenguer and C Leiva Santana},
  journal={Neurologia},
  year={2014},
  volume={29 7},
  pages={397-401}
}
INTRODUCTION The goals of this study were to compare the early diagnostic utility of Alzheimer disease biomarkers in the CSF with those in brain MRI in conditions found in our clinical practice, and to ascertain the diagnostic accuracy of both techniques used together. METHODS Between 2008 and 2009, we included 30 patients with mild cognitive impairment (MCI) who were examined using 1.5 Tesla brain MRI and AD biomarker analysis in CSF. MRI studies were evaluated by 2 radiologists according to… CONTINUE READING